AUG 22, 2016 11:54 AM PDT

Cutting Edge Techniques Yield Potential Treatment for Rare Genetic Disease

WRITTEN BY: Carmen Leitch
A research team led by Christopher J. Lengner of the University of Pennsylvania School of Veterinary Medicine and Brad Johnson of the Perelman School of Medicine have identified a link between telomeres and a biochemical cascade called the Wnt signaling pathway that could open up new treatment options for patients with telomere dysfunction. They reported their findings in Cell Stem Cell; the graphical abstract for the paper is seen below.
Credit: Cell Stem Cell Woo et al
Telomeres are the capped ends of chromosomes where they have a protective effect, and with every round of cell division, they get smaller. For more information on telomeres, check out the video below. Telomere shortening has been linked to aging and some disease. One such disease is dyskeratosis congenita (DC).
DC is a rare genetic disorder that can impact a variety of parts of the body, and is variable between patients. The three main features of the disease are altered skin pigmentation, poorly growing or misshapen nails, and white patches in the mouth. Other more serious symptoms can occur as well due to the effects the disease has on bone marrow, including increased cancer risk. Many people affected by DC carry a mutation in the DKC1 gene, which is critical to the telomerase enzyme. The clinical guidelines for the disease are discussed in the video below.
Using mice from Johnson's lab, the Lengner and Johnson research groups were able to connect the Wnt pathway to telomeres. They followed up on the finding with human tissues in culture to show that when the Wnt pathway is stimulated, intestinal dysfunction due to DC is reversed. The scientists hope their findings can help fight telomere dysfunction in a broad sense, which could have implications for aging and some cancers.

"What you see in the mutant mice and the dyskeratosis congenita patients is the consequence of having less telomerase activity in rapidly dividing tissues," explained Johnson, an Associate Professor of Pathology and Laboratory Medicine at Penn Medicine and the co-senior author of the study. "It's not the same thing as natural aging where you might have telomere defects in cells that don't have a lot of telomerase activity to begin with. But I think it's fair to say our findings inform an understanding of some of what might be happening as telomeres shorten in aging."

There are currently very few treatment options for DC patients. "Right now the main therapy for these patients is a bone marrow transplant," said Lengner, another co-senior author and an Assistant Professor in the Department of Biomedical Sciences at Penn Vet. "That can address the bone marrow failure but doesn't fix other problems associated with the disease, and especially not the risk of cancer. This work suggests a way to address the underlying cause of the disease."

The investigators knew from previous work that there could be a connection between the Wnt pathway and telomerase. They used a variety of new techniques to delve deeper.

Using induced pluripotent stem cells (iPSCs), reprogrammed adult cells that resemble embryonic stem cells, they were able to alter cells from both DC patients and healthy people in order to create many different types of cells.

The CRISPR/Cas9 gene-editing system was employed to both create a mutation in the DKC1 gene of the healthy stem cells, or to correct the mutation in unhealthy DC-derived cells. Want to know more about the CRISPR/Cas9 system? The video below, featuring one inventor of the technology, explains further. Those various cell lines would allow the researchers to rule out confounding effects from other parts of the genome.
Finally, organoids, or miniature, simplified versions of organs, were grown using the stem cells. In this case, the organ was the intestinal tube. Organoids derived from DC patients were only able to form so much of the tube before the process became dysfunctional and had shorter telomeres. The same thing was observed in organoids made from healthy stem cells that had been mutated. No such problems were seen in the organoids made from healthy individuals, or from DC patients that had been edited with CRISPR.

"We could see at the molecular level that this is accompanied by a failure to activate specific intestinal stem cell gene programs," Lengner explained, "specifically genes in the Wnt pathway." Since the Wnt pathway had been implicated, the researchers wanted to see if it could be an avenue for treatment.

After transplanting the organoids they’d created into mice (for a more clinically relevant model), the mice were treated with a Wnt pathway stimulator, lithium. In lithium-treated mice that received the DC-affected transplant, intestinal tissue structure was maintained. Basically, they were like the mice that got a transplant of an organoid made from a healthy patient.

This led the scientists to conclude that Wnt pathway activation can reverse the gastrointestinal distress caused by DC. They hope to extend these findings into therapies for tissues affected by this disorder.

Sources: AAAS/Eurekalert! via UPenn, Genetics Home Reference, Cell Stem Cell
 
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 01, 2021
Cell & Molecular Biology
Children Exposed to Famine Have a Lasting Epigenetic Impact
DEC 01, 2021
Children Exposed to Famine Have a Lasting Epigenetic Impact
Exposure to famine and prenatal exposure to famine has been consistently linked to a variety of health problems includin ...
DEC 02, 2021
Microbiology
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
DEC 02, 2021
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
Crimean-Congo hemorrhagic fever (CCHF) is a deadly disease, which is fatal in about 30 percent of cases. It's caused ...
DEC 08, 2021
Genetics & Genomics
GenElute™-E Single Spin DNA and RNA Purification Technology
DEC 08, 2021
GenElute™-E Single Spin DNA and RNA Purification Technology
Scientists in diverse lab settings often seek optimized technologies and methodologies that improve the quality of their ...
DEC 29, 2021
Genetics & Genomics
High-Throughput Tools Reveal New Proteins Involved in DNA Repair
DEC 29, 2021
High-Throughput Tools Reveal New Proteins Involved in DNA Repair
Our body is made up of trillions of cells, most of which contain a genome that suffers a lot of damage. That damage may ...
JAN 19, 2022
Genetics & Genomics
Targeting Proteins Linked to Huntington's & ALS With a New Gene Editing Tool
JAN 19, 2022
Targeting Proteins Linked to Huntington's & ALS With a New Gene Editing Tool
The CRISPR gene editing tool is often used with an enzyme called Cas9, which targets and cuts genomic DNA. While this te ...
JAN 24, 2022
Cell & Molecular Biology
Honey Bees Could Make Forensic Science More Reliable
JAN 24, 2022
Honey Bees Could Make Forensic Science More Reliable
Most methods used in forensic science have not been independently validated or verified by scientists, but some efforts ...
Loading Comments...